Community Investing Ideas

Global Weekly Picks

US$60
FV
90.4% undervalued intrinsic discount
19users have liked this narrative
3users have commented on this narrative
26users have followed this narrative
US$193.68
8.8% overvalued intrinsic discount
NateF's Fair Value
Revenue
18.84% p.a.
Profit Margin
7.52%
Future PE
108.82x
Price in 2029
US$283.75
US$49.35
34.5% undervalued intrinsic discount
NateF's Fair Value
Revenue
31.29% p.a.
Profit Margin
8.09%
Future PE
14.87x
Price in 2029
US$85.14
US$390.54
8.1% undervalued intrinsic discount
NateF's Fair Value
Revenue
6.79% p.a.
Profit Margin
3.69%
Future PE
13.33x
Price in 2029
US$546.7
JP¥7.61k
54.1% overvalued intrinsic discount
Serpentaire's Fair Value
Revenue
4% p.a.
Profit Margin
23%
Future PE
30x
Price in 2027
JP¥9.33k
SRTS logo
Sensus Healthcare

SRTS Market Outlook

Sensus Healthcare, Inc. (NASDAQ: SRTS) specializes in non-invasive treatments for skin conditions, notably through its Superficial Radiation Therapy (SRT) technology.Read more

View narrative
6users have liked this narrative
0users have commented on this narrative
43users have followed this narrative
US$13.42
71.5% undervalued intrinsic discount
NateF's Fair Value
Revenue
20.39% p.a.
Profit Margin
22.54%
Future PE
12.76x
Price in 2030
US$18.35